- All sections
- A - Human necessities
- A61B - Diagnosissurgeryidentification
- A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
Patent holdings for IPC class A61B 5/1473
Total number of patents in this class: 1649
10-year publication summary
|
128
|
129
|
200
|
159
|
200
|
155
|
147
|
132
|
137
|
62
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DexCom, Inc. | 1717 |
240 |
| Abbott Diabetes Care Inc. | 2064 |
200 |
| Medtronic MiniMed, Inc. | 1796 |
143 |
| Roche Diabetes Care, Inc. | 1502 |
49 |
| The Regents of the University of California | 20590 |
40 |
| Medtrum Technologies Inc. | 364 |
33 |
| F. Hoffmann-La Roche AG | 7847 |
26 |
| Terumo Kabushiki Kaisha | 5749 |
26 |
| Senseonics, Incorporated | 314 |
26 |
| California Institute of Technology | 4023 |
23 |
| Uxn Co., Ltd. | 37 |
23 |
| Roche Diabetes Care GmbH | 674 |
22 |
| Verily Life Sciences LLC | 1566 |
20 |
| Cardiac Pacemakers, Inc. | 2857 |
17 |
| ARKRAY, Inc. | 867 |
17 |
| Otsuka Pharmaceutical Co., Ltd. | 1504 |
17 |
| PHC Holdings Corporation | 717 |
17 |
| Bionime Corporation | 142 |
15 |
| Ascensia Diabetes Care Holdings AG | 602 |
13 |
| Biolinq, Inc. | 136 |
11 |
| Other owners | 671 |